NCT06439654Recruiting
Atlantic Lipid Lowering Treatment Optimization Program
Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias
Source: ClinicalTrials.gov · Last updated 3 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 28 May 2024
- Start date
- 1 Jul 2024
- Primary completion date
- 31 May 2027
- Lead sponsor
- Atlantic Health System
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT06439654
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 1 Jul 2024 to the primary completion date, 31 May 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals with a terminal illness
Other
- Individuals who are pregnant
- Individuals who are incarcerated
- Individuals who do not consent
Who the study is looking for
- LDL-C ≥160 mg/dL
- Untreated LDL-C ≥190 with family history of CAD
- Prior MI and currently without optimized lipid-lowering therapy
- Family history of CAD in first degree relative
- Personal history of CAD
- Untreated triglycerides \>500
- Elevated Lp(a) and/or high calcium scores
- Consenting individuals
Age in the registry: 18 years to 120 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atlantic Medical Group Coordinator of this site? Confirm its status | Clark | United States | Not yet recruiting |
| Atlantic Medical Group Coordinator of this site? Confirm its status | Springfield | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.